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ABSTRACT The b1a subunit of the skeletal muscle voltage-gated Ca
21 channel plays a fundamental role in the targeting of
the channel to the tubular system as well as in channel function. To determine whether this cytosolic auxiliary subunit is also
a regulatory protein of Ca21 release from the sarcoplasmic reticulum in vivo, we pressure-injected the b1a subunit into intact
adult mouse muscle ﬁbers and recorded, with Fluo-3 AM, the intracellular Ca21 signal induced by the action potential. We found
that the b1a subunit signiﬁcantly increased, within minutes, the amplitude of Ca
21 release without major changes in its time
course. b1a subunits with the carboxy-terminus region deleted did not show an effect on Ca
21 release. The possibility that
potentiation of Ca21 release is due to a direct interaction between the b1a subunit and the ryanodine receptor was ruled out by
bilayer experiments of RyR1 single-channel currents and also by Ca21 ﬂux experiments. Our data suggest that the b1a subunit
is capable of regulating E-C coupling in the short term and that the integrity of the carboxy-terminus region is essential for its
modulatory effect.
INTRODUCTION
Dihydropyridine receptors (DHP) play an essential role as
the voltage sensors that link excitation with contraction in
skeletal muscle (for reviews, see Rı´os and Pizarro and others
1–4). In addition to their role as voltage sensors, these re-
ceptors are also permeant to Ca21, generating a very slowly
activated L-type Ca21 current ((5) for a review, see Melzer
et al. (4)). DHP receptors are composed of the main subunit
a1s, and the auxiliary subunits, a2-d, b1, and g-subunits. The
a1s subunit (now referred to as the CaV1.1 channel (6)) contains
the pore (7), the voltage sensor of excitation-contraction
coupling, and the DHP binding sites (for reviews, see Rı´os and
Pizarro and others (1,8–10)).
The b1a subunit is the main isoform among the b1 subunits
present in skeletal muscle (11) and its role has been explored
by inactivating the b1 gene using gene targeting techniques.
This approach has revealed that this subunit plays an es-
sential role in the assembly of DHP receptors in their correct
position. b-null cells have undetectable levels of the a1s
subunit in the cell membrane and show greatly reduced
L-type Ca21 currents and charge movement (12,13), an
effect that can be reversed by the introduction of the cDNA
of the b1a subunit (14). However, much less is known about
the potential role of this auxiliary subunit as a modulatory
protein of E-C coupling, regulating Ca21 release in the short
term. In this regard, we have recently described that the
addition of the b1a subunit to a cell-free preparation enhances
the amplitude of L-type current within minutes, consistent
with a short-term modulatory role on CaV1.1 channels (15).
The aim of this study was to examine whether the b1a subunit
also has a short-term effect on Ca21 release induced by ac-
tion potentials in adult skeletal muscle ﬁbers.
Preliminary results have been published (16).
MATERIALS AND METHODS
Fiber preparation
BALB/c mice (aged ;9 weeks) were used. These were killed by cervical
dislocation, after which the ﬂexor digitorum brevis muscles (FDB) of the
hindlimbs were isolated and incubated at 34C for 60 min in a Ca21-Mg21-
free Tyrode solution plus 10% fetal calf serum (Gibco-Invitrogen, Carlsbad,
CA) and collagenase (0.5 mg/ml, type lV, Sigma, St. Louis, MO). The
muscles were then rinsed and dissociated by gently triturating the enzyme-
treated muscles through a ﬁre-polished Pasteur pipette with collagenase-free
Tyrode solution containing (mM): NaCl, 146; KCl, 5; CaCl2, 2; MgCl2, 1;
glucose, 11; HEPES, 10; at pH ¼ 7.4. The experiments were performed
according to the guidelines of the local animal care committee.
Molecular biology techniques
Production of the b1a subunit in COS-1 cells
We have described the expression and detailed puriﬁcation procedure of
the b1a subunit in COS-1 cells elsewhere (15). In brief, COS-1 cells were
transiently transfected with a plasmid containing the cDNA of the b1a
subunit (pSG5-Mb1a) under the control of the SV-40 promoter. Membrane
fraction samples of homogeneized COS-1 cells were loaded onto poly-
acrylamide gels and stained with Coomassie blue. The gel band that
contained the b1a subunit was identiﬁed by Western blots, cut, and puriﬁed
by electroelution methods according to Smith (17). After the electroelution
procedure, electrodialysis techniques were used to remove all traces of
sodium dodecyl sulfate, as described by Garcı´a et al. (15). The dried protein
was stored at 20C until used.
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Bacterial production and puriﬁcation of the b1a subunit
The coding fragment of the b1a subunit was liberated from the pSG5
expression vector mentioned above. To this end, pSG5-b1a was cleaved with
NheI (New England Biolabs, Beverly, MA). NheI sites are present in both
ends of the b1a fragment. The sticky ends of the fragment were ﬁlled with
Klenow polymerase and ligated at the SmaI site of the multiple cloning site
of the pQE-31 vector (Qiagen, Valencia, CA). This strategy generates an
in-frame cloning of the b1a protein. Escherichia coli DH5-a cells were
transformed with this construct and clones with the correct orientation of
the insert were selected to achieve transcription of the product with the
T5 promoter present in the vector. The deletion of the last 40 amino acids in
the carboxy-terminus region of the b1a subunit was achieved by cleavage
of pSG5-b1a plasmid with NotI. The plasmid contains a single recognition
site located downstream from the open reading frame. After that, DNA
was treated with Bal-31 exonuclease (New England Biolabs) for 15 min. To
estimate the size of the deleted products, we used NcoI andHincII to liberate
the 39 end of the b1a subunit and the products were subsequently sequenced.
The fragment containing the truncated b1a was liberated from the pSG5
vector by NheI and HincII (New England Biolabs). It was then ﬁlled with
Klenow polymerase and subcloned in the same way as the nontruncated b1a
subunit. Both clones were sequenced to conﬁrm the integrity of the open
reading frame with Sequenase kit (version 2.0, USB) and speciﬁc oligo-
nucleotides for pQE vectors. Deletion of 40 amino acids in the C-terminus
region of the b-subunit is not expected to alter the folding of the protein. In
fact, Bogdanov et al. (18) produced chimeras of b-subunits lacking more
amino acids in their C-terminus region than in this study and suggested that
no disruption in protein folding takes place. In addition, molecular models of
b-subunits have identiﬁed several domains that allow intramolecular in-
teractions, namely, SH3 domain, PDZ domain, and the GK domain (19,20).
None of these domains is located in the C-terminus region of the b-protein
and the domain organization of D2 and D4 domains is not altered by a similar
C-terminus deletion (21).
E. coli BL21(lDE3) (Novagen, San Diego, CA) cells were transformed
with the above constructs and used for mass production of the b1a subunit
protein and its truncated form. The cells were cultured in 100 ml of LB
medium in the presence of 100 mg/ml ampicillin and grown at 32C until
an A600 of 0.6 was reached. The production of the protein was induced by
1.0 mM isopropyl b-D-thiogalactopyranoside for 6 h at 32C. The cells
were pelleted and resuspended in 10 ml of NETN buffer (NaCl ¼ 120 mM,
Tris-HCl ¼ 20 mM, EDTA ¼ 1 mM, PSMF ¼ 1 mM, and 0.5% NP-40 at
pH ¼ 8.0). Cell lysis was achieved with the aid of a French press (Thermo
Spectronic, Shelton, CT) at a pressure of 600 psi, applied twice. The lysate
was centrifuged at 15,0003 g resulting in a pellet and in a clear supernatant
fraction. The b1a subunit protein was found in the pellet fraction and was
solubilized with 5 M urea. The truncated form of the b1a subunit was found
in the supernatant. The protein fractions were analyzed by SDS-PAGE and
stained with Coomassie blue. The b1a subunit was identiﬁed byWestern blot
as described elsewhere (15). The products were obtained by electroelution
techniques and the eluted protein products were precipitated with acetone.
Thereafter, the samples were dialyzed with water to remove the salt content.
Pressure injection techniques
To introduce the b1a subunit into muscle ﬁbers, we used an intracellular
micropipette to which pressure was applied. The micropipettes were pulled
in a Brown-Flaming horizontal puller (Sutter Instruments, San Francisco,
CA) from Kwik-ﬁll glass capillaries (WPI, New Haven, CT) and had an
average resistance of 25 MV when ﬁlled with 3 M KCl. They were mounted
in a plastic holder and driven by a hydraulic micromanipulator (Narishige
MO-150, Tokyo, Japan). Pipettes were ﬁlled with a solution containing
(mM): KCl, 140; MgCl2, 1; EGTA, 1; and HEPES, 10, at pH ¼ 7.1. Fibers
were impaled at a point located 125 mm from the position where light was
detected with the photodiode. The b1a subunit, puriﬁed either from COS-1
cells or from bacteria, was used at a concentration of 0.35 mg/ml. Most
experiments were performed with b1a subunits puriﬁed from COS-1 cells.
Experiments that were performed with b1a subunits from bacteria are clearly
indicated in the text. Control experiments involved pressure injection of
a heat-inactivated b1a subunit added at the same concentration or pressure
injection of the micropipette saline solution. In both cases, these control
injections gave similar results and are considered together in the Results
section. Two trains of pulses separated by a 30-s interval were delivered.
Each train consisted of ﬁve consecutive 150 kPa pressure pulses, each
lasting 600 ms. We estimate that this procedure allowed the injection of 40–
50 pl of solution. Action potentials were elicited by passing rectangular
current pulses between two platinum plate electrodes placed symmetrically
on either side of the muscle chamber.
The microinjected b1a subunit is expected to diffuse away from the point
of injection along the axis of the muscle ﬁber. To estimate the diffusion of
the b1a subunit in our experiments, we used Fick’s second law (Eq. 1). This
equation was used by Papadopoulos et al. (22) to account for the axial spread
of microinjected proteins in muscle. In Eq. 1, D is the diffusion coefﬁcient
and C is the concentration of the injected protein in the sarcoplasm that
changes as a function of time (t) and as a function of the distance from the
point of injection (x). Equation 1 describes the proportionality between the
change of C along the diffusion pathway @C/@x and the change in con-
centration with time @C/@T. This equation assumes a one-dimensional dif-
fusion process with an inﬁnite extension of the diffusion path.
dC=dt ¼ D3 d2C=dx2: (1)
The diffusion coefﬁcient (D) in Eq. 1 was measured experimentally in
the myoplasm of muscle ﬁbers by Papadopoulos et al. (22) for proteins of
different masses. In our estimations we used D ¼ 6.2 3 108 cm2 s1. This
value corresponds to the diffusion coefﬁcient measured for hemoglobin (22),
a protein that has a similar mass (64.5 kDa) to that of the b1a subunit (55 kDa
(10)). The analytical solution of Eq. 1 can be achieved using a Dirac delta
function applied at t ¼ 0. The solution is Eq. 2 where A is an amplitude
factor.
C ¼ Að4pDtÞ1=23 exp½ðx2Þ=4Dt: (2)
Optical techniques
We used Fluo-3 AM (1–10 mM) (Molecular Probes, Eugene, OR) to monitor
the levels of intracellular Ca21. This dye undergoes large ﬂuorescence
changes upon Ca21 binding, it has a large dynamic range, low com-
partmentalization (23), and it has been used extensively in muscle (24–26).
Fibers were mounted in a chamber placed on the stage of an Optiphot
microscope (Nikon, Tokyo, Japan). The ﬂuorescence emitted by a prese-
lected region of a stained muscle ﬁber, illuminated episcopically with
monochromatic light at a wavelength of 485 nm, was ﬁltered with a high-
pass barrier ﬁlter (cut-on wavelength 535 nm), and detected with a low noise
photodiode connected in a photovoltaic conﬁguration. The basal ﬂuores-
cence (F) from the same region of the muscle ﬁber was recorded con-
tinuously on video tape. Its mean value during 300 ms before electrical
stimulation, was used to scale Ca21 signals as DF/F. This procedure mini-
mizes the possible effects of changes in the concentration of the dye on
ﬂuorescence signals and it has been used extensively by others (24,27). No
attempts were made to calculate the actual myoplasmic Ca21 concentration.
To prevent mechanical artifacts, intact single ﬁbers were suspended in
0.35% agar gel, following a procedure similar to that described in (28)
except that we used a lower agar concentration and that our experiments
were performed at a lower temperature (20–22C).
Ca21 leak measurements
Skeletal muscle heavy sarcoplasmic reticulum (SR) microsomes were
obtained following procedures by Saito et al. (29). The net rate of Ca21 leak
from these microsomes was measured at room temperature (20–24C) with
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a spectrophotometer (Cory 50, Varian, Palo Alto, CA) using the Ca21-
sensitive dye antipyrylazo III (APIII). Changes in Ca21 concentration over
time were measured as the absorbance difference between 710 and 790 nm
as described in (30). Brieﬂy, microsomes (50 mg protein) were incubated
with 1 ml of assay solution containing 100 mM potassium phosphate, 0.2
mMAPIII, 4 mMMgCl2, and 2 mMATP (pH 7). Microsomes were actively
preloaded with Ca21 (via the SR Ca21 ATPase) by adding 3 aliquots of 40
nM CaCl2 while stirring. The microsomes were then incubated for 5 min
with standard buffer (control) or buffer containing ruthenium red (5 mM),
normal b1a subunit, or the truncated b1a subunit. After this incubation
period, 25 mM cyclopiazonic acid (CPZ) was added to inhibit the SR Ca21
ATPase and then Ca21 leak from the microsomes was monitored. When
caffeine (2.5 mM) was applied, it was applied simultaneously with CPZ.
Ca21 leak rate in each experimental condition was measured from the slope
of the APIII Ca21 signal.
Electrophysiological methods
Dissociated FDB muscle ﬁbers were used in voltage clamp experiments. To
minimize mechanical artifacts during measurements of membrane currents,
ﬁbers were not embedded in agar as in optical experiments. Instead, move-
ment artifacts were greatly suppressed by a previous incubation for 3 h in the
cell permeant calcium buffer BAPTA AM (10 mM) (Molecular Probes).
The whole-cell patch-clamp technique was used to record CaV1.1
currents (31). Pipettes (1–1.2 MV) were double-pulled from hard glass
(KIMAX-51; Kimble Glass, Toledo, OH) and were ﬁlled with 5 ml of the
internal solution. CaV1.1 currents were measured 10 min after achieving the
whole cell conﬁguration. The b1a subunit was tested by adding 0.30–0.35
mg ml1 of the b1a subunit to the pipette solution. Currents were recorded
with an Axopatch 200A (Axon Instruments, Foster City, CA) ampliﬁer;
60–80% of the series resistance was electronically compensated.
To measure charge movement, command pulses of 60-ms duration and
variable amplitude were delivered. The pulse sequence was bracketed by 16
consecutive hyperpolarizing control pulses, 20 mV from the holding
potential (Eh) that was set at 100 mV. The currents generated during these
pulses were used to subtract linear membrane components, to calculate the
linear membrane capacitance, and to measure the leakage current during the
experiment.
The voltage dependence of activation of nonlinear charge movement was
ﬁtted to the Boltzmann function:
Q ¼ Qmax=f11 exp½ðV  VmÞ=kg; (3)
where Qmax is the maximum value of charge, Vm is the membrane potential,
V is the potential where Q¼ 0.5 Qmax, and k is a measure of the steepness of
the curve.
To measure Ca21 currents (ICa) the same pulse protocol was used except
that the duration of the pulses was 750 ms and Eh ¼ 80 mV. The interval
between pulses was 4 s. The peak Ca21 current values were ﬁtted to Eq. 4,
which is similar to that used by Wang et al. (32) to describe the current-
voltage relationship of L-type Ca21 currents in muscle ﬁbers.
Im ¼ Gmax3 ðVm  VrevÞ=f11 exp½V  VmÞ=kg: (4)
In Eq. 4, Gmax is the maximum conductance and Vrev is the reversal
potential. The other parameters have the same meaning as in Eq. 3.
Single channel measurements of skeletal RyR1 channels were recorded
by fusing SR microsomes into artiﬁcial planar lipid bilayers as previously
described by Copello et al. (33). Brieﬂy, planar bilayers were formed by
painting a mixture (5:4:1) of phosphatydilethanolamine, phosphatydilserine,
and phosphatydilcholine (50 mg/ml decane) across a 100-mm hole sepa-
rating two ;1-ml solutions. One solution (trans) contained 250 mM
HEPES/50 mM Ca(OH)2 (pH 7.4) and was clamped to 0 mV using an
Axopatch 200B patch-clamp ampliﬁer (Axon Instruments). The other
solution (cis) was held at virtual ground and contained 1 mM CsCl, 250 mM
HEPES/Tris (pH 7.4), and 1 mM CaCl2. The SR microsomes (5 mg protein)
were added to the cis solution while stirring. In this situation, the RyR1
channels incorporate with their cytosolic surface facing the cis solution.
Channels were identiﬁed by their high conductance, Ca21 selectivity, and
gating characteristics. After RyR1 incorporation, the cis solution was
perfused with 30 vol of 250 mM HEPES/Tris (pH 7.4) and the free Ca21
level was adjusted to ;2 mM (1.4 mM CaCl2, 1 mM BAPTA, and 1 mM
DiBromoBAPTA). The cis solution also contained 7 mM ATP and 5.5 mM
Mg21. Single-channel recordings were made before and after addition of b1a
subunit (1–4 mM; stirring for 2 min) to the cis solution. Recordings were
ﬁltered at 1000 Hz and digitized at 20 KHz with a Digidata 1360 acquisition
system (Axon Instruments). Data were analyzed using pClamp9 (Axon
Instruments). Open probability (Po) was determined from at least 8 min of
recording.
Electrophysiological and optical experiments were carried out at room
temperature (20–22C).
Solutions
The external solution employed to record ICa contained (mM): 10 Ca
21, 140
TEACH3SO3 (tetraethylamonium methanesulphonate), and 2 MgCl2. The
pipette solution contained (mM): 140 Cs-aspartate, 5 MgCl2, and 10 EGTA.
The composition of the external solution used to record charge movement
was similar, except that the concentration of external Ca21 was reduced to
1 mM. The presence of Ca21 was required to maintain the stability of our
recordings because ﬁbers do not generally tolerate the absence of Ca21 well.
We did not use Ca21 channel blockers because they alter the voltage
dependence of charge movement and may have deleterious effects on leakage
currents (34). Due to the contamination of ‘‘off’’ charge by tail Ca21 currents,
we restricted our measurements to ‘‘on’’ charge only. Contamination of ‘‘on’’
charge by ICa is likely to be minor because charge moves at more negative
potentials than ICa and the time course of activation of ICa is very slow com-
pared to that of ‘‘on’’ charge (32). In fact, it has been shown that integration of
‘‘on’’ charge provides an accurate measure of charge movement in Ca21-
contaning solutions, even without Ca21 channel blockers (35).
Extracellular and intracellular solutions were buffered with HEPES (10
mM) at pH 7.2 and 7.1, respectively. Chemicals were obtained from either
Sigma Chemical or Aldrich Chemical (St. Louis, MO).
The ﬁtting of numerical formulas to experimental data employed a
nonlinear, least squares algorithm. Parameter values given in the text are
expressed as mean 6 SE. Student’s t-test was used at the level p , 0.05 to
calculate statistical signiﬁcance of the data.
RESULTS
Actions of the b1a subunit on intracellular
Ca21 signals
Fig. 1 A shows Ca21 transients from a control experiment
recorded from a single FDB skeletal muscle ﬁber. The
recorded region was located ;125 mm from the point of
injection. Illustrated are Ca21 signals recorded before and
after the injection of a control solution (at t¼ 0). The change in
ﬂuorescence of the dye is expressed as a DF/F ratio. The
transient increase in Fluo-3 ﬂuorescence induced by an action
potential rapidly reaches a peak and decays quickly initially
and then, more slowly to prestimulus levels. The ﬁber was
stimulated extracellularly at the times indicated (in minutes)
by the numbers above each trace. The Ca21 transients were
quite similar before and after pressure injection indicating that
the injection,by itself, hadonlyminoreffects onCa21 release.A
very different result was observed when the b1a subunit was
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injected. The b1a subunit had remarkable effects on Ca
21
signals generated by action potentials (Fig. 1 B). The amplitude
of the Ca21 transients increased and this potentiation was evi-
dent a few minutes after the b1a subunit was pressure injected.
The potentiation reached a peak;20min after the injection and
then slowly declined to preinjection values. The time course of
b1a subunit action is summarized in Fig. 2. To compare data
from different experiments, the ratio between the peak amp-
litude of the Ca21 signal, at any given time, relative to its mean
value before pressure injection, was computed for every ex-
periment. Their average values are shown in Fig. 2. Each
symbol represents mean values (6 SE). Open symbols
represent results from ﬁbers that were pressure injected with
a control solution. Solid circles represent results from ﬁbers that
were pressure injectedwith theb1a subunit. The smooth curve is
the solution ofEq. 2with the parameters indicated in the legend.
It describes rather well the time course of the effect of the b1a
subunit on peakDF/F signals. Themost signiﬁcant effect of the
b1a subunit was to increase the peak amplitude of the Ca
21
transient. There were only minor changes in their time course
that were not statistically signiﬁcant. Before pressure injection
of the b1a subunit, the half-time and decay-time constant of the
Ca21 transients averaged42.86 4.9 (n¼ 13)msand40.96 4.5
(n¼ 13) ms, respectively. After the injection of theb1a subunit,
these parameters were 46.16 4.8 (n¼ 13) ms and 38.66 4.3
(n ¼ 13) ms, respectively.
Actions of the b1a subunit on charge movement
of muscle ﬁbers
The b1a subunit regulates the amplitude of L-type currents
that ﬂow through a1s, the principal subunit of the Ca
21
channel in muscle. Because the a1s subunit also generates the
charge movement associated with Ca21 release, it is im-
portant to determine if the increase in the amplitude of the Ca
transient, described above, is associated with similar changes
in charge movement.
To measure charge movement, voltage clamp experiments
were carried out in FDB muscle ﬁbers. We chose this prep-
aration because of the small ﬁber size that favors diffusion of
the b1a subunit and provides better space clamp than large
ﬁbers. The mean ﬁber length and diameter were 565 6 26
mm (n ¼ 12) and 29 6 2 mm (n ¼ 12), respectively. The
mean capacitance was 899 6 72 pF (n ¼ 12). The expected
capacitance, assuming a value of 1 mF cm2, was 508 6 26
pF (n ¼ 12).
Fig. 3 A illustrates the relationship between the amount
of mobilized charge and membrane potential from control
experiments. Each symbol represents average values 6 SE.
The smooth curve is the best ﬁt of Eq. 3 with the parameters
indicated in the legend. The Boltzmann parameters in Fig. 3
A are similar to those found by Collet et al. (36) in FDB
muscle ﬁbers. The inset shows nonlinear currents from a
representative experiment at the potential indicated (in mV)
FIGURE 1 The action of the b1a subunit upon Ca signals. (A) The records
show Fluo-3 Ca21 signals associated with action potentials from a muscle
ﬁber that was pressure injected with a control solution. (B) Ca21 signals from
a separate ﬁber to which the b1a subunit was pressure injected. The numbers
below each trace indicate time in minutes computed since microinjection was
done.
FIGURE 2 The time course of action of the b1a subunit. Circles represent
mean values (6 SE) of peak Ca21 signals as a function of time. Values were
normalized for every experiment as: Peak j / Peak a, where j is every
individual peak Ca21 signal value and a is the average peak value of signals
recorded before pressure injection; (s) represents values of normalized
records obtained from pressure-injected ﬁbers with the control solution; (d)
represents values from pressure-injected ﬁbers with the b1a subunit. The
arrow indicates time of microinjection. Unless otherwise indicated by the
number in parentheses, each symbol represents the mean value of at least
ﬁve to seven separate experiments. The smooth curve is the graph of Eq. 2 at
x ¼ 125 mm and D ¼ 6.2 3 108 cm2 s1.
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with the numbers beside each trace. Fig. 3 B summarizes
results from experiments in which the pipette contained the
b1a subunit. The maximum charge values and the voltage
dependence of charge movement were very similar to those
of the control experiments. This indicates that, in the short
term, the b1a subunit has no effect on charge movement.
Actions of the b1a subunit on Ca
21 currents
The absence of b1a subunit action on charge movement
(demonstrated above) is not due to poor diffusion of the b1a
subunit through the patch pipette and into the ﬁber. This is
shown here by demonstrating a clear action of this auxiliary
subunit on L-type Ca21 current in voltage clamp experi-
ments performed in muscle ﬁbers. We found that the b1a
subunit increased the amplitude of ICa (Fig. 4, A–D). Fig. 4 A
illustrates control currents at the potentials indicated (in mV).
The amplitude and time course of ICa depended on the
membrane depolarization level. ICa was not sustained, but
declined during the pulse by a voltage-dependent inactiva-
tion process. Fig. 4 B illustrates records from a similar
experiment except for the presence of the b1a subunit. The
amplitude of ICa was distinctly larger at all potentials
although their time course was not substantially changed.
For example, the time to peak of ICa at130 mV was 262 ms
in panel A, and 270 ms in panel B. Likewise, the time to peak
of ICa at large depolarizations averaged 247.2 6 12.9 ms
(n ¼ 21) in control experiments and it averaged 233.0 6
11.2 ms (n ¼ 16) in the presence of the b1a subunit.
Fig. 4 C shows the average current-voltage relationship
derived from several experiments as that illustrated in Fig. 4,
A and B. Open symbols represent the control experiment and
solid symbols experiments in the presence of the b1a subunit.
FIGURE 3 The action of the b1a subunit on charge movement. (A) (s)
Represents mean values (6 SE) of charge movement as a function of
membrane potential from control experiments (n¼ 16). The smooth curve is
the best ﬁt of Eq. 3 to the data points with Qmax ¼ 31.3 nC/mF, V ¼ 36.6
mV, and k ¼ 15.0 mV. (B) (d) Represents mean values (6 SE) of charge
movement as a function of membrane potential in the presence of the b1a
subunit (n ¼ 16). Eh ¼ 100 mV. The smooth curve is the Boltzmann ﬁt
with Qmax ¼ 30.2 nC/mF, V ¼ 36.0 mV, and k ¼ 13.9 mV. The insets in
panels A and B show records of nonlinear currents from representative
experiments. The amplitude and timescale in panel A also applies to panel B.
FIGURE 4 The action of the b1a subunit on L-type currents. (A) The
records show nonlinear currents from a control experiment at the poten-
tials indicated with the numbers (in mV) between traces. (B) Records of
membrane currents at the same potentials from a separate experiment
performed in the presence of the b1a subunit. Currents were normalized per
unit capacitance. (C) The current-voltage relationship of Ca21 currents.
Symbols represent mean values (6 SE) of peak Ca21 currents from control
experiments (s) (n ¼ 21) and from experiments performed in the presence
of the b1a subunit (d) (n ¼ 16). Eh ¼ 80 mV. The smooth curve is the
best ﬁt of Eq. 4 to the data points with Gmax ¼ 122.5 mS/mF, V ¼ 3.4 mV, k
¼ 4.2 mV, and Vrev ¼ 70.2 mV (s) and Gmax ¼ 163.6 mS/mF, V ¼ 7.0 mV,
k ¼ 3.1 mV, and Vrev ¼ 81.7 mV (d). (D) The voltage dependence of the
normalized conductance. Mean current density values from panel C were
divided by Gmax3 (Vm  Vrev). Smooth curves are best ﬁts of a Boltzmann
function with V¼ 3.4 mV and k ¼ 4.1 mV (s) and V¼ 7.0 mV and k¼ 3.0
mV (d).
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Compared to currents recorded under control conditions,
currents recorded in the presence of the b1a subunit were
signiﬁcantly larger ( p , 0.05) at positive potentials. The
smooth curves through the data points in Fig. 4 C represent
the best ﬁt of Eq. 4 with the parameters indicated in the
legend. The most signiﬁcant effect of the b1a subunit on the
I-V curve was to increase the values of Gmax. There were
only minor shifts along the voltage axis, as illustrated in
Fig. 4 D, which represents the relationship between the
normalized conductance and membrane potential in both
experimental conditions.
Role of the carboxy-terminus on potentiation
of Ca21 signals
The carboxy-terminus region of the b1a subunit is essential
for the restoration of E-C coupling in b-null myotubes to
levels similar to those of control cells (37). Therefore, the
role of this region in the potentiation of Ca21 transients
induced by action potentials was examined. Fig. 5 A shows
representative Ca21 signals from a ﬁber that was pressure
injected with the b1a subunit puriﬁed from bacteria.
Consistent with the data illustrated in Fig. 1 B, there was a
gradual increase in the amplitude of the signals that reached
a peak value 16 min after injection. After that, there was a
slow return to control values. In contrast, when a truncated
b1a subunit (lacking 40 amino acids in the carboxy-terminus
region) was pressure-injected, the amplitude of the Ca21
signals remained unchanged. Similar results were observed
in 15 other experiments. The peak DF/F values averaged
4.1 6 0.2 (n ¼ 16) before pressure injection and 3.9 6 0.2
(n ¼ 16), 20 min after the truncated form of the b1a subunit
was pressure injected. Likewise, electrophysiological experi-
ments revealed that the truncated form of the b1a subunit had
no effect on L-type currents or on charge movement.
Peak ICa values were6.26 0.7 mA/mF (n¼ 5) in control
experiments and 5.96 0.7 mA/mF (n ¼ 6) in the presence of
truncated b-subunits. The Boltzmann parameters from
charge movement experiments were: Qmax ¼ 33.5 6 2.3
nC/mF, V ¼ 40.1 6 2.0 mV, and k ¼ 14.6 6 2.1 mV (n ¼
5) for control experiments and Qmax ¼ 32.1 6 3.8 nC/mF,
V ¼ 39.2 6 1.9 mV, and k ¼ 15.1 6 2.7 mV (n ¼ 7) from
experiments performed with the truncated b1a protein.
Action of the b1a subunit on SR Ca
21
release channels
The possibility that the b1a subunit protein is acting directly
on SR Ca21 release channels was tested by performing SR
Ca21 leak and bilayer experiments. Fig. 6 A shows the ac-
tion of the b1a subunit on RyR-mediated Ca
21 leak from a
population of heavy SR membrane microsomes. The SR
FIGURE 5 The involvement of the carboxy-terminus region of the b1a
subunit on Ca21 signal potentiation. (A) The records show Fluo-3 Ca21
signals associated with action potentials from a muscle ﬁber that was
pressure injected with the full-length b1a subunit puriﬁed from bacteria.
(B) Ca21 signals from a separate ﬁber to which a truncated form of the
b1a subunit, lacking 40 amino acids in the carboxy-terminus region, was
pressure injected. The numbers below each trace indicate time in minutes
computed since microinjection was carried out. The dotted lines indicate
resting ﬂuorescence and peak DF/F before pressure injection.
FIGURE 6 The action of the b1a subunit on Ca
21 leak from SR
microsomes and on single RyR1 channel function. (A) The Ca21 leak rate
of Ca21 loaded skeletal muscle SR microsomes (50 mg) was recorded after
SERCA pump blockade by 25 mM cyclopiazonic acid (CPZ). Leak was
measured in different experimental conditions (h, 2.5 mM caffeine; ),
5 mM ruthenium red; d, b1a subunit; s, truncated b1a subunit). (B) Single
RyR1 channel activity in planar lipid bilayers was monitored in the absence
(control) and presence of the b1a subunit. The charge carrier was Ca
21 and
holding potential was 0 mV. The solution in the cytosolic chamber had 2
mM free Ca21, 5.5 mM total Mg21, and 7.0 mM total ATP.
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microsome population was actively Ca21 loaded using the
ATP driven SERCA pump. The pump was then blocked with
CPZ and the rate of Ca21 leak from the microsomes measured
in ﬁve different experimental conditions (control, caffeine,
ruthenium red, b1a, and truncated b1a). Open diamonds and
squares show leak rates in the presence of ruthenium red
and caffeine, respectively. Ruthenium red slowed leak rate
whereas caffeine accelerated the leak. The average leak rate
(nM Ca mg protein1min1) was 17.7 6 2.4 (n ¼ 6) in
ruthenium red and 489 6 55 (n ¼ 6) in caffeine. Open and
solid circles show leak rates in the presence of the b1a subunit
and truncated b1a subunit, respectively. The average leak rate
was 64.96 7.7 (n¼ 6) with the b1a subunit added and 62.86
8.8 (n ¼ 6) when the truncated b1a subunit was added. The
leak rates with the normal and truncated subunits were
virtually identical and overlap control leak data (i.e., leak after
CPZ application without another added reagent; data not
shown). This result suggests that the b1a subunit does not
activate RyR-mediated Ca21 release from SR microsomes.
Fig. 6 B shows the action of the b1a subunit on single RyR1
channel function. The SR microsomes used above were
fused into planar lipid bilayers and RyR1 channel activity
recorded. Open events are shown as upward deﬂections from
the zero current level (marked). In most cases, multiple
RyR1 channels were incorporated into the bilayers. The b1a
subunit was added to the cytosolic chamber in six different
experiments. Representative channel recordings are shown.
Addition of the b1a subunit did not induce a detectable
change in unit Ca21 current or open probability. The average
open probability (nPo) was 0.16 6 0.04 (n ¼ 6) in control
and 0.236 0.05 (n¼ 6) after the b1a subunit was added. This
result suggests that the b1a subunit does not affect the RyR1
channel when it was directly applied to the isolated channel
in a bilayer. The SR Ca21 leak and single channel data (Fig.
6) combined imply that the b1a subunit potentiation of the
action potential induced Ca21 transient in muscle ﬁbers is
not likely due to a direct action of the b1a subunit on the
RyR1 channel.
DISCUSSION
Role of the b-subunit on Ca21 release
The major ﬁnding of this study is that the acute application of
b1a subunits increases the amount of Ca
21 that is released by
an action potential. Although the underlying mechanism of
the potentiation of Ca21 signals by b1a subunits is unknown,
the fact that no changes in charge movement were observed
suggests that the b1a subunit improves the efﬁciency of the
coupling mechanism, where the same number of voltage
sensors would open more Ca21 release channels. Alterna-
tively, the b1a subunit may improve the effectiveness of the
Ca21-induced Ca21 release mechanism that is known to
operate in skeletal muscle, although Ca21-induced Ca21
release is a minor component in mammalian skeletal muscle
(38) and no direct action of the b1a subunit on the RyR1
channel was detected in our studies.
An alternative explanation would involve binding of the
b1a subunit to intracellular factors that regulate Ca
21 release.
The SR Ca release process is regulated by numerous factors
in cells. The presence of some of these factors (e.g., sorcin)
may chronically inhibit the SR Ca21 release process. If these
chronically inhibitory factors also interact with the b1a sub-
unit, the application of excess b1a subunits could alter the
way this factor regulates release. The addition of excess b1a
protein could hypothetically result in larger Ca21 release
simply by interacting with this factor. Based on the current
absence of data supporting this alternative interpretation, we
believe an increase in coupling efﬁciency is more likely the
underlying mechanism involved.
From a structural point of view, potentiation of Ca21
signals could be explained in two ways. The ﬁrst possibility
is that not all a1s subunits in the transverse tubular system
(TTS) membranes are associated with b1a subunits. In this
scenario, the exogenously added b1a subunit would bind to
free a1s subunits to exert their action. However, this is very
unlikely because the b1a subunit is essential for the target-
ing of the channel (12) and thus all correctly targeted a1s
subunits should have associated b1a subunits. As discussed
by Dolphin (39), however, it is possible that the afﬁnity of
a1s subunits for b1a subunits is reduced once the channel has
reached the TTS membranes. The second possibility is that
there are multiple binding sites between a1s and b1a subunits
(40). In this scenario, additional b1a subunits would bind to
a single a1s subunit modulating the interaction between the
a1s subunit and the RyR1 channel. In either case, the b1a
subunit would modulate the signal transduction process in-
volved in EC coupling.
Role of the C-terminus region
Our data further indicate that the carboxy-terminus region
of the b1a subunit is essential for potentiation of Ca
21
transients. Previous work has established that this region is
required for restoration of normal E-C coupling in b-null
cells (37,41) and it is different from the high afﬁnity site in b
(the BID region), a 30-amino-acid N-terminal region of its
second conserved domain (42), that interacts with a high-
afﬁnity site in the a-subunit (the AID region) (43,44). It is
thus possible that higher order regulatory complexes are
formed where the b1a subunit binds to the a1s subunit in
different regions. The high-afﬁnity binding site would
provide the structural basis for the strong interaction between
a1s and b1a subunits allowing the trafﬁcking and expression
of a1s in TTS. The regulatory effects of the b1a subunit on
Ca21 release that we report here, might result from the in-
teraction of a1sb1a complexes with a second b1a subunit,
possibly mediated by low-afﬁnity sites. This last possibility
is fully compatible with these ﬁndings, since the time course
of the effect of the b1a subunit on Ca
21 signals could be
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described by a purely diffusional process. The additional
interaction of a b1a subunit with the CaV1.1 channel would
not necessarily lead to the formation of a stable complex as
it has been described for the b-modulation of the a1c channel
(45). Also, low-afﬁnity sites in the a1 subunit of Ca
21
channels have been described in regions distant from the
AID region (46,44,47,48), and based on the effects of in-
creasing concentrations of b3 on a1A subunit, it has been
suggested that there are two distinct binding processes for
b-subunits (49). A low-afﬁnity interaction between a1s and
b1a subunits would be more easily switched ‘‘on’’ and ‘‘off’’
as expected from a regulatory process.
Is the a1s subunit function limited by
the b-subunit?
These results suggest a different role of b-subunits from the
classical action on trafﬁcking of the channels to the plasma
membrane. The capability of the b1a subunit to potentiate
Ca21 transients in the short term, suggests that this auxiliary
subunit is a limiting factor regulating the amount of Ca21
that is released by the SR. Therefore, the a1 subunits of
skeletal muscle are not normally saturated with b, raising the
possibility that Ca release may be regulated by b-subunits
under physiological conditions. In this regard, there are
several previous observations suggesting that the function of
a1 subunits is limited by the amount of b-subunits available.
Thus, when CaV1.1 channels in a cell-free preparation are
exposed to additional b1a subunits, a potentiation of L-type
Ca21 channel currents is observed (15). Also, overexpres-
sion of b-subunits in adult heart cells increases whole-cell,
L-type Ca21 currents, and maximal gating charge (48),
whereas overexpression of a1c in a transgenic mouse model
does not lead to increases in Ca21 channel current density
values (50). The observations of Yamaguchi et al. (51) are
also consistent with the idea that the concentration of
b-subunits is limiting: the injection of b3 subunit protein
increases CaV1.2 currents in Xenopus oocytes and it has
acute effects on the biophysical properties of the channel.
A physiological modulation of Ca release by b-subunits
would not be expected to involve a very high concentration
of these proteins. In this regard, we used in these experiments
an amount of b-protein that is distinctly lower (at least ﬁve
times) than the one used in the experiments of Yamaguchi
et al. (51) and Opatowsky et al. (52). A physiological role of
the b-subunits on Ca release in muscle would require the
presence of an intracellular pool of b-proteins that could be
shuttled to the membrane where they would bind to a1
subunits leading to changes in the interaction between a1
subunits and RyR1. The presence of b-subunits in skeletal
muscle, not associated with a1 subunits, has indeed been
described in tissue homogenates (53).
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